Compile Data Set for Download or QSAR
Report error Found 14 Enz. Inhib. hit(s) with all data for entry = 813
TargetEgl nine homolog 1(Human)
Shenyang Sunshine Pharmaceutical

US Patent
LigandPNGBDBM292143(US10100051, Compound 12 | 2-(2-((2,3-dihydrobenzo[...)
Affinity DataIC50: 210nMT: 2°CAssay Description:To a NETN (20 mM Tris.HCl, 100 mM NaCl, 1 mM EDTA, 0.5% NP-40, 1 mM PMSF) buffer containing 200 μM ascorbic acid, 20 μM α-ketoglutaric...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2019
Entry Details
US Patent

TargetEgl nine homolog 1(Human)
Shenyang Sunshine Pharmaceutical

US Patent
LigandPNGBDBM292144(US10100051, Compound 13 | 2-(2-([1,1′-biphen...)
Affinity DataIC50: 230nMT: 2°CAssay Description:To a NETN (20 mM Tris.HCl, 100 mM NaCl, 1 mM EDTA, 0.5% NP-40, 1 mM PMSF) buffer containing 200 μM ascorbic acid, 20 μM α-ketoglutaric...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2019
Entry Details
US Patent

TargetEgl nine homolog 1(Human)
Shenyang Sunshine Pharmaceutical

US Patent
LigandPNGBDBM292141(US10100051, Compound 10 | (2-(2-(4-bromophenoxy)-5...)
Affinity DataIC50: 330nMT: 2°CAssay Description:To a NETN (20 mM Tris.HCl, 100 mM NaCl, 1 mM EDTA, 0.5% NP-40, 1 mM PMSF) buffer containing 200 μM ascorbic acid, 20 μM α-ketoglutaric...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2019
Entry Details
US Patent

TargetEgl nine homolog 1(Human)
Shenyang Sunshine Pharmaceutical

US Patent
LigandPNGBDBM292142(US10100051, Compound 11 | 2-(2-(3-(tert-butyl)phen...)
Affinity DataIC50: 510nMT: 2°CAssay Description:To a NETN (20 mM Tris.HCl, 100 mM NaCl, 1 mM EDTA, 0.5% NP-40, 1 mM PMSF) buffer containing 200 μM ascorbic acid, 20 μM α-ketoglutaric...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2019
Entry Details
US Patent

TargetEgl nine homolog 1(Human)
Shenyang Sunshine Pharmaceutical

US Patent
LigandPNGBDBM292145(US10100051, Compound 14 | 2-(5-hydroxy-2-(4-methox...)
Affinity DataIC50: 1.40E+3nMT: 2°CAssay Description:To a NETN (20 mM Tris.HCl, 100 mM NaCl, 1 mM EDTA, 0.5% NP-40, 1 mM PMSF) buffer containing 200 μM ascorbic acid, 20 μM α-ketoglutaric...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2019
Entry Details
US Patent

TargetEgl nine homolog 1(Human)
Shenyang Sunshine Pharmaceutical

US Patent
LigandPNGBDBM292135(US10100051, Compound 4 | 2-(2-(4-cyanophenoxy)-5-h...)
Affinity DataIC50: 2.20E+3nMT: 2°CAssay Description:To a NETN (20 mM Tris.HCl, 100 mM NaCl, 1 mM EDTA, 0.5% NP-40, 1 mM PMSF) buffer containing 200 μM ascorbic acid, 20 μM α-ketoglutaric...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2019
Entry Details
US Patent

TargetEgl nine homolog 1(Human)
Shenyang Sunshine Pharmaceutical

US Patent
LigandPNGBDBM292138(US10100051, Compound 7 | 2-(2-(4-chlorophenoxy)-5-...)
Affinity DataIC50: 4.00E+3nMT: 2°CAssay Description:To a NETN (20 mM Tris.HCl, 100 mM NaCl, 1 mM EDTA, 0.5% NP-40, 1 mM PMSF) buffer containing 200 μM ascorbic acid, 20 μM α-ketoglutaric...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2019
Entry Details
US Patent

TargetEgl nine homolog 1(Human)
Shenyang Sunshine Pharmaceutical

US Patent
LigandPNGBDBM292140(US10100051, Compound 9 | 2-(2-(3-cyanophenoxy)-5-h...)
Affinity DataIC50: 5.10E+3nMT: 2°CAssay Description:To a NETN (20 mM Tris.HCl, 100 mM NaCl, 1 mM EDTA, 0.5% NP-40, 1 mM PMSF) buffer containing 200 μM ascorbic acid, 20 μM α-ketoglutaric...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2019
Entry Details
US Patent

TargetEgl nine homolog 1(Human)
Shenyang Sunshine Pharmaceutical

US Patent
LigandPNGBDBM292137(US10100051, Compound 6 | 2-(5-hydroxy-2-phenoxy-1,...)
Affinity DataIC50: 6.90E+3nMT: 2°CAssay Description:To a NETN (20 mM Tris.HCl, 100 mM NaCl, 1 mM EDTA, 0.5% NP-40, 1 mM PMSF) buffer containing 200 μM ascorbic acid, 20 μM α-ketoglutaric...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2019
Entry Details
US Patent

TargetEgl nine homolog 1(Human)
Shenyang Sunshine Pharmaceutical

US Patent
LigandPNGBDBM292132(US10100051, Compound 1 | 2-(5-hydroxy-8-methyl-2-p...)
Affinity DataIC50: 3.30E+4nMT: 2°CAssay Description:To a NETN (20 mM Tris.HCl, 100 mM NaCl, 1 mM EDTA, 0.5% NP-40, 1 mM PMSF) buffer containing 200 μM ascorbic acid, 20 μM α-ketoglutaric...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2019
Entry Details
US Patent

TargetEgl nine homolog 1(Human)
Shenyang Sunshine Pharmaceutical

US Patent
LigandPNGBDBM292139(US10100051, Compound 8 | (2-5-hydroxy-8-methyl-2-(...)
Affinity DataIC50: 3.60E+4nMT: 2°CAssay Description:To a NETN (20 mM Tris.HCl, 100 mM NaCl, 1 mM EDTA, 0.5% NP-40, 1 mM PMSF) buffer containing 200 μM ascorbic acid, 20 μM α-ketoglutaric...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2019
Entry Details
US Patent

TargetEgl nine homolog 1(Human)
Shenyang Sunshine Pharmaceutical

US Patent
LigandPNGBDBM292134(US10100051, Compound 3 | 2-(2-(3-chlorophenoxy)-5-...)
Affinity DataIC50: 4.80E+4nMT: 2°CAssay Description:To a NETN (20 mM Tris.HCl, 100 mM NaCl, 1 mM EDTA, 0.5% NP-40, 1 mM PMSF) buffer containing 200 μM ascorbic acid, 20 μM α-ketoglutaric...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2019
Entry Details
US Patent

TargetEgl nine homolog 1(Human)
Shenyang Sunshine Pharmaceutical

US Patent
LigandPNGBDBM292136(US10100051, Compound 5 | 2-(2-(4-(tert-butyl)pheno...)
Affinity DataIC50: 5.90E+4nMT: 2°CAssay Description:To a NETN (20 mM Tris.HCl, 100 mM NaCl, 1 mM EDTA, 0.5% NP-40, 1 mM PMSF) buffer containing 200 μM ascorbic acid, 20 μM α-ketoglutaric...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2019
Entry Details
US Patent

TargetEgl nine homolog 1(Human)
Shenyang Sunshine Pharmaceutical

US Patent
LigandPNGBDBM292133(US10100051, Compound 2 | (2-(2-(4-fluorophenoxy)-5...)
Affinity DataIC50: 7.30E+4nMT: 2°CAssay Description:To a NETN (20 mM Tris.HCl, 100 mM NaCl, 1 mM EDTA, 0.5% NP-40, 1 mM PMSF) buffer containing 200 μM ascorbic acid, 20 μM α-ketoglutaric...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2019
Entry Details
US Patent